We are monitoring the impact of COVID-19 on APAC Protein Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5064
Share on
Share on

Asia Pacific Protein Therapeutics Market Research Report - Segmented By Product, Application, Therapeutic Modalities & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 5064
Pages: 145

APAC Protein Therapeutics Market Size (2020 to 2025)

As per the research report, the size of the Asia Pacific Protein Therapeutics market was worth USD 31.99 billion in 2020. It is expected to grow at a CAGR of 7.3% and value USD 45.49 billion by 2025. It captures 20% of the global market.

Protein therapeutics are most often employed in the treatment of chronic ailments like cancer etc. This market has huge potential in the coming years.

An increasing number of people suffering from chronic diseases coupled with rapid advancements in the medical sciences resulting in the development of plasma-based therapies are driving this market's growth.

On the other hand, vague government policies and cumbersome administrative framework conjoined with the high cost are inhibiting the market growth.

This research report on the APAC protein therapeutics market has been segmented and sub-segmented into the following categories:

By Product:

  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Follicle Stimulating Hormone

By Application:

  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Cancer
  • Hormonal Disorders
  • Genetic Disorders
  • Others

By Therapeutic Modalities: 

  • Protein Diagnostics
  • Protein Vaccines
  • Protein Therapeutics with Special Targeting Activity
  • Protein Therapeutics with Enzymatic Or Regulatory Activity

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

In 2019, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment that is anticipated to undergo the fastest growth till 2025.

Geographically, growing awareness about these novel treatment methods in the emerging economies makes it likely that Asia Pacific will grow with the highest CAGR in the forecast period. China leads the market in this region.

Notable participants dominating the Asia Pacific Protein Therapeutics Market profiled in this report are Baxter International Inc., Eli Lilly, and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.

1. Introduction      

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods

               1.4 General Study Assumptions                 

2. Research Methodology                

               2.1 Introduction   

               2.2 Research Phases                      

    2.2.1 Secondary Research           

    2.2.2 Primary Research 

    2.2.3 Econometric Modelling      

    2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview           

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology  

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)          

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                  

               5.1 Product                       

    5.1.1 Introduction           

    5.1.2 Monoclonal Antibodies      

    5.1.3 Insulin       

    5.1.4 Fusion Protein       

    5.1.5 Erythropoietin       

    5.1.6 Interferon

    5.1.7 Human Growth Hormone  

    5.1.8 Follicle Stimulating Hormone          

    5.1.9 Y-o-Y Growth Analysis, By Product

    5.1.10 Market Attractiveness Analysis, By Product           

    5.1.11 Market Share Analysis, By Product            

               5.2 Therapeutic Modalities                         

    5.2.1 Introduction           

    5.2.2 Protein diagnostics             

    5.2.3 Protein vaccines   

    5.2.4 Protein therapeutics with special targeting activity

    5.2.5 Protein therapeutics with enzymatic or regulatory activity 

    5.2.6 Y-o-Y Growth Analysis, By Therapeutic Modalities  

    5.2.7 Market Attractiveness Analysis, By Therapeutic Modalities

    5.2.8 Market Share Analysis, By Therapeutic Modalities

               5.3 Application                 

    5.3.1 Introduction           

    5.3.2 Metabolic Disorders            

    5.3.3 Immunologic Disorders      

    5.3.4 Hematological Disorders    

    5.3.5 Cancer      

    5.3.6 Hormonal Disorders            

    5.3.7 Genetic Disorders 

    5.3.8 Others      

    5.3.9 Y-o-Y Growth Analysis, By Application         

    5.3.10 Market Attractiveness Analysis, By Application     

    5.3.11 Market Share Analysis, By Application      

6. Geographical Analysis                  

               6.1 Introduction   

    6.1.1 Regional Trends    

    6.1.2 Impact Analysis     

    6.1.3 Y-o-Y Growth Analysis        

                   6.1.3.1 By Geographical Area

                   6.1.3.2 By Product

                   6.1.3.3 By Therapeutic Modalities

                   6.1.3.4 By Application

    6.1.4  Market Attractiveness Analysis      

                   6.1.4.1 By Geographical Area

                   6.1.4.2 By Product

                   6.1.4.3 By Therapeutic Modalities

                   6.1.4.4 By Application

    6.1.5  Market Share Analysis       

                   6.1.5.1 By Geographical Area

                   6.1.5.2 By Product

                   6.1.5.3 By Therapeutic Modalities

                   6.1.5.4 By Application

               6.2 China

               6.3 India  

               6.4 Japan

               6.5 South Korea               

               6.6 Australia                     

7. Strategic Analysis            

               7.1 PESTLE analysis                        

    7.1.1 Political    

    7.1.2 Economic 

    7.1.3 Social        

    7.1.4 Technological        

    7.1.5 Legal         

    7.1.6 Environmental       

               7.2 Porter’s Five analysis   

    7.2.1 Bargaining Power of Suppliers         

    7.2.2 Bargaining Power of Consumers     

    7.2.3 Threat of New Entrants      

    7.2.4 Threat of Substitute Products and Services

    7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis             

               8.1 Abbott Laboratories               

    8.1.1 Overview 

    8.1.2 Product Analysis   

    8.1.3 Financial analysis  

    8.1.4 Recent Developments        

    8.1.5 SWOT analysis       

    8.1.6 Analyst View          

               8.2 Amgen Inc.                

               8.3 Baxter International Inc.                      

               8.4 Eli Lilly and Company  

               8.5 F. Hoffmann-La Roche Ltd.                  

               8.6 Johnson & Johnson                

               8.7 Merck & Co. Inc.                     

               8.8 Novo Nordisk A/S                    

               8.9 Pfizer Inc.                   

               8.10 Sanofi                       

9. Competitive Landscape               

               9.1 Market share analysis 

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities               

Appendix                

               a) List of Tables                

               b) List of Figures   

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  2. Asia Pacific Monoclonal Antibodies Market, By Region, From 2020 to 2025 (USD Billion)
  3. Asia Pacific Insulin Market, By Region, From 2020 to 2025 (USD Billion)
  4. Asia Pacific Fusion Protein Market, By Region, From 2020 to 2025 (USD Billion)
  5. Asia Pacific Erythropoietin Market, By Region, From 2020 to 2025 (USD Billion)
  6. Asia Pacific Interferon Market, By Region, From 2020 to 2025 (USD Billion)
  7. Asia Pacific Human Growth Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  8. Asia Pacific Follicle Stimulating Hormone Market, By Region, From 2020 to 2025 (USD Billion)
  9. Asia Pacific Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  10. Asia Pacific Metabolic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  11. Asia Pacific Immunologic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  12. Asia Pacific Hematological Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  13. Asia Pacific Cancer Market, By Region, From 2020 to 2025 (USD Billion)
  14. Asia Pacific Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  15. Asia Pacific Genetic Disorders Market, By Region, From 2020 to 2025 (USD Billion)
  16. Asia Pacific Others Market, By Region, From 2020 to 2025 (USD Billion)
  17. Asia Pacific Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  18. Asia Pacific Protein diagnostics Market, By Region, From 2020 to 2025 (USD Billion)
  19. Asia Pacific Protein vaccines Market, By Region, From 2020 to 2025 (USD Billion)
  20. Asia Pacific Protein therapeutics with special targeting activity Market, By Region, From 2020 to 2025 (USD Billion)
  21. Asia Pacific Protein therapeutics with enzymatic or regulatory activity Market, By Region, From 2020 to 2025 (USD Billion)
  22. Japan Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  23. Japan Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  24. Japan Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  25. China Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  26. China Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  27. China Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  28. India Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  29. India Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  30. India Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  31. Australia Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  32. Australia Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  33. Australia Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)
  34. South Korea Protein Therapeutics Market, By Product, From 2020 to 2025 (USD Billion)
  35. South Korea Protein Therapeutics Market, By Application, From 2020 to 2025 (USD Billion)
  36. South Korea Protein Therapeutics Market, By Therapeuctic Modalities, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample